{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:20:32Z","timestamp":1790875232481,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1093\/rheumatology\/ken483","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T05:08:06Z","timestamp":1243832886000},"page":"iii32-iii35","source":"Crossref","is-referenced-by-count":90,"title":["Renal complications and scleroderma renal crisis"],"prefix":"10.1093","volume":"48","author":[{"given":"C. P.","family":"Denton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,5,28]]},"reference":[{"key":"key\n\t\t\t\t20170703115441_B1","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.10589","article-title":"Predictors and outcome of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial","volume":"46","author":"DeMarco","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703115441_B2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1445-5994.2003.00358.x","article-title":"Scleroderma renal crisis: poor outcome despite aggressive antihypertensive therapy","volume":"33","author":"Walker","year":"2003","journal-title":"Intern Med J"},{"key":"key\n\t\t\t\t20170703115441_B3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma \u2013 clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key\n\t\t\t\t20170703115441_B4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-57-2-305","article-title":"An historical account of the study of systemic sclerosis (diffuse scleroderma)","volume":"57","author":"Rodnan","year":"1962","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170703115441_B5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0738-081X(94)90329-8","article-title":"Renal involvement in systemic sclerosis","volume":"12","author":"Steen","year":"1994","journal-title":"Clin Dermatol"},{"key":"key\n\t\t\t\t20170703115441_B6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170703115441_B7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170703115441_B8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t20170703115441_B9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0019-5359.30346","article-title":"Scleroderma renal crisis","volume":"61","author":"Steen","year":"2007","journal-title":"Indian J Med Sci"},{"key":"key\n\t\t\t\t20170703115441_B10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170703115441_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine"},{"key":"key\n\t\t\t\t20170703115441_B12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11926-004-0059-3","article-title":"The pathogenesis of fibrosis and renal disease in scleroderma: recent insights from glomerulosclerosis","volume":"6","author":"Lee","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"key\n\t\t\t\t20170703115441_B13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s100670050132","article-title":"Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis","volume":"18","author":"Kobayashi","year":"1999","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170703115441_B14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study in 50 patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170703115441_B15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/rheumatology\/35.11.1122","article-title":"Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population","volume":"35","author":"Bryan","year":"1996","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t20170703115441_B16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170703115441_B17","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703115441_B18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"key\n\t\t\t\t20170703115441_B19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/37.1.15","article-title":"Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis","volume":"37","author":"Bunn","year":"1998","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t20170703115441_B20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","article-title":"Anti-fibrillarin antibodies in systemic sclerosis","volume":"40","author":"Tormey","year":"2001","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170703115441_B21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","article-title":"Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment","volume":"42","author":"Kingdon","year":"2003","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170703115441_B22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000151620.17905.ee","article-title":"Microangiopathic hemolysis and renal failure in malignant hypertension","volume":"45","author":"Van den Born","year":"2005","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170703115441_B23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","article-title":"Normotensive renal failure in systemic sclerosis","volume":"32","author":"Helfrich","year":"1989","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703115441_B24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-75-3-369","article-title":"Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients","volume":"75","author":"Medsger TA","year":"1971","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170703115441_B25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128071-200102050-00006","article-title":"Treatment of systemic sclerosis","volume":"2","author":"Steen","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"key\n\t\t\t\t20170703115441_B26","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/S0755-4982(06)74931-4","article-title":"[Scleroderma renal crisis.]","volume":"35","author":"Teixeira","year":"2006","journal-title":"Presse Med"},{"key":"key\n\t\t\t\t20170703115441_B27","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets \u2013 a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170703115441_B28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.lfs.2003.07.034","article-title":"The endothelin receptor antagonist ameliorates the hypertensive phenotypes of transgenic hypertensive mice with renin-angiotensin genes and discloses roles of organ specific activation of endothelin system in transgenic mice","volume":"74","author":"Maki","year":"2004","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20170703115441_B29","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.22036","article-title":"Endothelin axis polymorphisms in patients with scleroderma","volume":"54","author":"Fonseca","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/48\/suppl_3\/iii32\/18096299\/ken483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:56:52Z","timestamp":1503536212000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/ken483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":29,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2009,5,28]]},"published-print":{"date-parts":[[2006,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/ken483","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}